An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects

NCT03084718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: CHF 718 pMDI
DRUG: Placebo pMDI
DRUG: Beclomethasone Dipropionate (BDP)

Sponsor

Chiesi Farmaceutici S.p.A.